Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Santos EJF, Farisogullari B, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases. Santos EJF, et al. Among authors: farisogullari b. RMD Open. 2023 Aug;9(3):e003350. doi: 10.1136/rmdopen-2023-003350. RMD Open. 2023. PMID: 37604639 Free PMC article.
COVID-19-associated arthritis: an emerging new entity?
Farisogullari B, Pinto AS, Machado PM. Farisogullari B, et al. RMD Open. 2022 Sep;8(2):e002026. doi: 10.1136/rmdopen-2021-002026. RMD Open. 2022. PMID: 36100294 Free PMC article. Review.
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Dures E, Farisoğulları B, Santos EJF, Molto A, Feldthusen C, Harris C, Elling-Audersch C, Connolly D, Elefante E, Estévez-López F, Bini I, Primdahl J, Hoeper K, Urban M, van de Laar MAFJ, Redondo M, Böhm P, Amarnani R, Hayward R, Geenen R, Rednic S, Pettersson S, Thomsen T, Uhlig T, Ritschl V, Machado PM. Dures E, et al. Among authors: farisogullari b. Ann Rheum Dis. 2023 Nov 22:ard-2023-224514. doi: 10.1136/ard-2023-224514. Online ahead of print. Ann Rheum Dis. 2023. PMID: 38050029
Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Farisogullari B, Santos EJF, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases; EULAR taskforce on Recommendations for the management of fatigue in people withinflammatory rheumatic diseases. Farisogullari B, et al. RMD Open. 2023 Dec 6;9(4):e003349. doi: 10.1136/rmdopen-2023-003349. RMD Open. 2023. PMID: 38056919 Free PMC article.
Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience.
Bilgin E, Ceylan F, Duran E, Farisoğullari B, Bölek EÇ, Yardimci GK, Kiliç L, Akdoğan A, Karadağ Ö, Apraş Bilgen ŞŞ, Kiraz S, Ertenli Aİ, Kalyoncu U. Bilgin E, et al. Among authors: farisogullari b. Turk J Med Sci. 2021 Feb 26;51(1):297-308. doi: 10.3906/sag-2007-123. Turk J Med Sci. 2021. PMID: 32979899 Free PMC article.
Anxiety levels before biologic initiation and changes with treatment in patients with psoriatic arthritis: HUR-BIO biologic registry results.
Ayan G, Farisogulları B, Bilgin E, Bolek EC, KübraYardımcı G, Duran E, Ozsoy Z, Uzun GS, Kilic L, Akdoğan A, Karadag O, Bilgen ŞA, Kiraz S, Ertenli Aİ, Kalyoncu U. Ayan G, et al. Among authors: farisogullari b. Clin Rheumatol. 2022 May;41(5):1439-1446. doi: 10.1007/s10067-021-06012-y. Epub 2022 Jan 27. Clin Rheumatol. 2022. PMID: 35088209
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates.
Sandal Uzun G, Taghiyeva A, Çakır İY, Moral K, Yardımcı GK, Bölek EÇ, Farisoğulları B, Duran E, Ayan G, Özsoy Z, Ekici M, Unaldı E, Germe ŞA, Fırlatan B, Kart-Bayram GS, Bilgin E, Kılıç L, Karadağ Ö, Akdoğan A, Bilgen ŞA, Kiraz S, Ertenli AI, Kalyoncu U. Sandal Uzun G, et al. Among authors: farisogullari b. Int J Rheum Dis. 2024 Jan;27(1):e14967. doi: 10.1111/1756-185X.14967. Epub 2023 Dec 6. Int J Rheum Dis. 2024. PMID: 38057290
Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry.
Duran E, Ozturk ZO, Bilgin E, Büyükaşık Y, Dizdar O, Yardimci GK, Farisogullari B, Özsoy Z, Ayan G, Uzun GS, Ekici M, Unaldi E, Kilic L, Akdoğan A, Karadag O, Bilgen ŞA, Kiraz S, Kalyoncu U, Ertenli AI. Duran E, et al. Among authors: farisogullari b. Rheumatol Ther. 2023 Aug;10(4):969-981. doi: 10.1007/s40744-023-00563-z. Epub 2023 Jun 9. Rheumatol Ther. 2023. PMID: 37294405 Free PMC article.
27 results